s6y DNIB UNWIND, INC. 10-Q

DNIB UNWIND, INC. 10-Q, filed May 7, 2015: IDEA: XBRL DOCUMENT

Stockholders' Equity
3 Months Ended
Mar. 31, 2015
Equity [Abstract]  
Stockholders' Equity

8. STOCKHOLDERS’ EQUITY

At-the-Market Facility—In October 2014, we entered into an at-the-market sales agreement (“Sales Agreement”) with Cowen & Company, LLC (“Cowen”) pursuant to which we may from time to time, at our option, offer and sell shares of our common stock having an aggregate offering price of up to $40 million through Cowen, acting as our sales agent. Upon delivery of a placement notice by us and subject to the terms and conditions of the Sales Agreement, Cowen will use its commercially reasonable efforts to sell shares of our common stock, based upon our instructions. We have provided Cowen with customary indemnification rights, and Cowen will be entitled to a commission of up to 3.0% of the gross proceeds from sales of shares of our common stock under the Sales Agreement. Sales of shares of our common stock, if any, under the Sales Agreement may be made by any method permitted by law that is deemed an “at the market” offering as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made through the Nasdaq Global Select Market, on any other existing trading market for our common stock or to or through a market maker. We may also authorize Cowen to sell shares in negotiated transactions. We have no obligation to sell shares of our common stock and cannot provide any assurances that we will issue any shares pursuant to the Sales Agreement. We may also suspend the offering of shares of our common stock upon notice and subject to other conditions under the Sales Agreement or may at any time upon notice terminate the Sales Agreement. As of March 31, 2015, we have not sold any shares of common stock under the Sales Agreement.

Equity Raise—In February 2015, we completed an underwritten public offering of 3,739,130 units at the public offering price of $5.75 per unit. Each unit consisted of one share of our common stock and six-tenths (0.6) of a warrant to purchase one share of our common stock with an exercise price of $6.60 per share. We received net proceeds of approximately $20 million after deducting underwriting discounts and commissions and offering expenses payable by us and not including any future proceeds from the exercise of the warrants.

The warrants were exercisable immediately upon their initial issuance date and will expire five years from the date of issuance. The shares of common stock and the warrants were immediately separable and were issued separately. The warrants contain weighted-average anti-dilution protection upon the issuance of any common stock, or securities convertible into common stock or certain other issuances at a price below the then-existing exercise price of the warrants, with certain exceptions, including but not limited to securities issued pursuant to equity compensation plans or arrangements, currently outstanding warrants, securities issued pursuant to shareholder rights plans, securities issued pursuant to certain strategic transactions or financings, and the first $30 million of securities sold under the Sales Agreement with Cowen that would otherwise cause an adjustment. The warrants are being recorded at fair value on our condensed consolidated balance sheets as a liability and changes in fair value are included in change in fair value of warrant liability on our condensed consolidated statements of operations.

The assumptions used in calculating the fair value of the warrants represent management’s best estimates. The warrants were valued at March 31, 2015 and on the issuance date using a Monte Carlo valuation model (see Note 5, “Fair Value Measurements”) using estimates of future funding probabilities and the following parameters:

  As of  
  March 31, 2015     Upon Issuance  

Expected volatility

  89 %      88 % 

Risk-free interest rate

  1.34 %      1.48 % 

Expected dividend yield

  0 %      0 % 

Expected term (years)

  4.85     5.00

Stock-Based Compensation—We have recorded aggregate stock-based compensation expense related to the issuance of stock option awards in the following line items in the accompanying Condensed Consolidated Statements of Operations (in thousands):

  Three Months Ended
March 31,
 
  2015   2014  

Research and development

$ 242 $ 522

General and administrative

  568   325

 

 

 

 

 

 

Total

$ 810 $ 847

 

 

 

 

 

 

Stock Options

As of March 31, 2015, there were 820,154 shares of common stock available for future grant under the 2013 Incentive Award Plan (the “2013 Plan”).

During the three months ended March 31, 2015, we granted 566,590 options to employees. The weighted average exercise price and the weighted-average grant-date fair value of options granted for the three months ended March 31, 2015 were $5.95 per share and $3.74 per share, respectively. The fair value of the grants is being expensed over the vesting period of the options (four years) on a straight-line basis as the services are being provided.

As of March 31, 2015, there was $6.5 million (includes compensation for options containing performance conditions) of unrecognized compensation cost related to the stock options granted under the 2006 Stock Incentive Plan and the 2013 Plan. The compensation is expected to be recognized over the remaining requisite service period for options with a service condition, and upon the probability of achievement of performance conditions, as defined in the option agreement, for options with performance conditions. The weighted average remaining requisite service period was 3.1 years at March 31, 2015.

Additionally, during the three months ended March 31, 2015, our president chief executive officer resigned. In connection with his resignation and separation agreement, we accelerated the vesting of all equity and equity-based awards held as of the effective date of his resignation. In connection with this modification, we recognized an additional $0.2 million in stock-based compensation expense during the three months ended March 31, 2015.